Identification of the BAFF-R H159Y mutation in biopsy specimens from patients with NHL
| NHL subtype | Number screened | Number positive for BAFF-R H159Y | Percent positive for BAFF-R H159Y |
| % | |||
| DLBCL | n = 42 | n = 2 | 4.8 |
| FL | n = 41 | n = 4 | 10 |
| Lymphoplasmacytic lymphoma | n = 22 | n = 1 | 4.5 |
| MALT | n = 24 | n = 1 | 4.1 |
| NHL subtype | Number screened | Number positive for BAFF-R H159Y | Percent positive for BAFF-R H159Y |
| % | |||
| DLBCL | n = 42 | n = 2 | 4.8 |
| FL | n = 41 | n = 4 | 10 |
| Lymphoplasmacytic lymphoma | n = 22 | n = 1 | 4.5 |
| MALT | n = 24 | n = 1 | 4.1 |
NHL subtype was determined by a board-certified Mayo Clinic Hematopathologist.